Burke, Jr.; Terrence R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Burke, Jr.; Terrence R..The latest application filed is for "peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use".

Company Profile

3.18.8

Burke, Jr.; Terrence R. - Bethesda MD
Burke, Jr.; Terrence R - Bethesda MD
Burke, Jr.; Terrence R. - West Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use Grant 10,905,769 - Burke, Jr. , et al. February 2, 2	2021-02-02
Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use Grant 10,266,565 - Burke, Jr. , et al.	2019-04-23
Compounds for inhibiting drug-resistant strains of HIV-1 integrase Grant 10,208,035 - Zhao , et al. Feb	2019-02-19
Peptide And Peptide Mimetic Binding Antagonists Of Polo-like Kinase 1 Polo Box Domain And Methods Of Use App 20180296686 - Burke, JR.; Terrence R. ; et al.	2018-10-18
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use Grant 10,047,122 - Qian , et al. August 14, 2	2018-08-14
Compounds For Inhibiting Drug-resistant Strains Of Hiv-1 Integrase App 20170305904 - Zhao; Xue Zhi ; et al.	2017-10-26
Compounds for inhibiting drug-resistant strains of HIV-1 integrase Grant 9,676,771 - Zhao , et al. June 13, 2	2017-06-13
Compounds For Inhibiting Drug-resistant Strains Of Hiv-1 Integrase App 20160083382 - Zhao; Xue Zhi ; et al.	2016-03-24
Peptide And Peptide Mimetic Binding Antagonists Of Polo-like Kinase 1 Polo Box Domain And Methods Of Use App 20160039872 - Qian; Wenjian ; et al.	2016-02-11
Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use Grant 9,175,038 - Burke, Jr. , et al. November 3, 2	2015-11-03
Selenocysteine Mediated Hybrid Antibody Molecules App 20150104383 - Rader; Christoph ; et al.	2015-04-16
Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain And Methods Of Use App 20140142044 - Burke, JR.; Terrence R. ; et al.	2014-05-22
Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain And Methods Of Use App 20120065146 - Burke, JR.; Terrence R. ; et al.	2012-03-15
Inhibition of cell motility, angiogenesis, and metastasis Grant 7,871,981 - Bottaro , et al. January 18, 2	2011-01-18
Phenylanine derivatives Grant 7,825,216 - Burke, Jr. , et al. November 2, 2	2010-11-02
SH2 domain binding inhibitors Grant 7,767,645 - Burke, Jr. , et al. August 3, 2	2010-08-03
SH2 domain binding inhibitors Grant 7,425,537 - Burke, Jr. , et al. September 16, 2	2008-09-16
Phenylalanine derivatives Grant 7,226,991 - Burke, Jr. , et al. June 5, 2	2007-06-05
Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain Grant 7,132,392 - Bottaro , et al. November 7, 2	2006-11-07
SH2 domain binding inhibitors Grant 6,977,241 - Burke, Jr. , et al. December 20, 2	2005-12-20
Acylated oligopeptide derivatives having cell signal inhibiting activity Grant 6,307,090 - Burke, Jr. , et al. October 23, 2	2001-10-23
Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis Grant 5,200,546 - Burke, Jr. , et al. April 6, 1	1993-04-06
Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5.alpha.-epoxy 6.beta.-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT) Grant 4,775,759 - Rice , et al. October 4, 1	1988-10-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.